DiaMedica Therapeutics, Inc. Quarterly report pursuant to Section 13 or 15(d)

Note 8 - Accrued Liabilities

3 Months Ended

Mar. 31, 2022

8. Accrued Liabilities

Accrued liabilities consisted of the following (in thousands):

	March 31, 2022		December 31, 2021
Accrued clinical trial costs	$	538	$	284
Accrued research and other professional fees		305		191
Accrued compensation		116		484
Other liabilities		8		7
Total accrued liabilities	$	967	$	966